title: Peritoneal cytology in endometrial cancer: a review.
abstract: Utilization of literature review to evaluate peritoneal cytology as a test for the detection of malignant cells in the peritoneal cavity is limited by the size of the study populations, varied use of preoperative radiation, the lack of consistent methodology for specimen retrieval and processing, and the inherent subjectivity of cytologic interpretation. A standardized methodology for retrieval and processing of peritoneal cytologic specimens should be developed to allow meaningful comparisons of future studies. However, certain conclusions are permitted from published data: 1. The incidence of positive peritoneal cytology is 11.4 per cent among 3091 patients with FIGO stage I endometrial cancer. 2. The depth of the uterus does not influence the incidence of positive peritoneal cytology. 3. Positive peritoneal cytology is predictive of other known prognostic factors including advanced histologic grade, depth of myometrial invasion, and pelvic/periaortic lymph node metastases. 4. The presence of malignant cells in the peritoneal washings from some patients with no myometrial invasion and the high incidence of lymph node metastases in other patients with positive peritoneal cytology suggest that malignant cells gain access to the peritoneal cavity in a variety of ways. It is unclear whether each of these modes of access result in viable tumor cells with the potential for viable metastasis. The high incidence of lymph node metastasis in such patients suggests that lymphatic dissemination of malignant cells plays a significant role in the development of positive peritoneal cytology. In this setting positive peritoneal cytology clearly identifies that individual at high risk for recurrence.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, Maryland.
authors.forename: R
authors.initials: R
authors.lastname: McLellan
authors.forename: M B
authors.initials: MB
authors.lastname: Dillon
authors.forename: J L
authors.initials: JL
authors.lastname: Currie
authors.forename: N B
authors.initials: NB
authors.lastname: Rosenshein
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000473:pathology; D001202:Ascitic Fluid / Q000166:cytology*; D003581:Cytodiagnosis; D005260:Female; D006801:Humans; D010533:Peritoneal Lavage; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000473:pathology